Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptor.

GPCRs adrenoceptor docking drug discovery machine learning structure-activity relationship

Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
10 2022
Historique:
received: 09 05 2022
accepted: 21 06 2022
entrez: 27 8 2022
pubmed: 28 8 2022
medline: 31 8 2022
Statut: ppublish

Résumé

G protein-coupled receptors (GPCRs) are valuable therapeutic targets for many diseases. A central question of GPCR drug discovery is to understand what determines the agonism or antagonism of ligands that bind them. Ligands exert their action via the interactions in the ligand binding pocket. We hypothesized that there is a common set of receptor interactions made by ligands of diverse structures that mediate their action and that among a large dataset of different ligands, the functionally important interactions will be over-represented. We computationally docked ~2700 known β2AR ligands to multiple β2AR structures, generating ca 75 000 docking poses and predicted all atomic interactions between the receptor and the ligand. We used machine learning (ML) techniques to identify specific interactions that correlate with the agonist or antagonist activity of these ligands. We demonstrate with the application of ML methods that it is possible to identify the key interactions associated with agonism or antagonism of ligands. The most representative interactions for agonist ligands involve K97

Identifiants

pubmed: 36029004
doi: 10.1002/prp2.994
pmc: PMC9418666
doi:

Substances chimiques

Ligands 0
Receptors, Adrenergic, beta-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00994

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.

Références

J Cheminform. 2013 Jan 24;5(1):7
pubmed: 23343401
F1000Res. 2019 Aug 29;8:
pubmed: 31508197
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Br J Pharmacol. 2021 Oct;178 Suppl 1:S27-S156
pubmed: 34529832
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
Sci Rep. 2016 Jun 24;6:28288
pubmed: 27339552
Nat Struct Mol Biol. 2018 Jan;25(1):4-12
pubmed: 29323277
J Med Chem. 2004 Jan 15;47(2):337-44
pubmed: 14711306
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Nature. 2013 Oct 24;502(7472):575-579
pubmed: 24056936
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294
pubmed: 34718737
Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021
pubmed: 31691834
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
J Biol Chem. 2002 Oct 25;277(43):40989-96
pubmed: 12167654
Nat Rev Drug Discov. 2013 Mar;12(3):205-16
pubmed: 23411724
Pharmacol Res Perspect. 2022 Oct;10(5):e00994
pubmed: 36029004
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Sci Rep. 2016 Oct 05;6:34736
pubmed: 27703221
Biochim Biophys Acta. 1975 Oct 20;405(2):442-51
pubmed: 1180967
J Chem Inf Model. 2007 Jan-Feb;47(1):195-207
pubmed: 17238265
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Respir Physiol Neurobiol. 2003 Sep 16;137(2-3):179-95
pubmed: 14516725
Am J Ther. 2008 Nov-Dec;15(6):565-76
pubmed: 19127141
Respir Med. 2019 Sep;156:47-52
pubmed: 31425937
Nature. 2011 Jul 19;477(7366):549-55
pubmed: 21772288
Nat Methods. 2020 Aug;17(8):777-787
pubmed: 32661425
Cell. 2018 Jan 11;172(1-2):41-54.e19
pubmed: 29249361
Methods Enzymol. 2002;343:329-71
pubmed: 11665578
J Chem Inf Model. 2015 May 26;55(5):1045-61
pubmed: 25848966
Pharmacol Rev. 2010 Jun;62(2):265-304
pubmed: 20392808
Nature. 2016 Jul 21;535(7612):448-52
pubmed: 27409812
Nucleic Acids Res. 2018 Jan 4;46(D1):D440-D446
pubmed: 29155946
Lancet. 1964 May 16;1(7342):1080-1
pubmed: 14132613
J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
pubmed: 15667143
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):1942-51
pubmed: 15554663
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72
pubmed: 16381955
J Cheminform. 2018 Mar 16;10(1):15
pubmed: 29549526
Curr Med Chem. 2012;19(8):1090-109
pubmed: 22300046
Br J Pharmacol. 2011 May;163(1):4-17
pubmed: 21232045
Science. 2020 Jul 31;369(6503):
pubmed: 32732395
J Mol Biol. 2017 Feb 3;429(3):365-371
pubmed: 27964945

Auteurs

Mireia Jiménez-Rosés (M)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Bradley Angus Morgan (BA)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
School of Computer Science, University of Birmingham, Birmingham, UK.
The Alan Turing Institute, London, UK.
MRC IMPACT Doctoral Training Programme, Universities of Birmingham, Leicester and Nottingham, Midlands, UK.

Maria Jimenez Sigstad (M)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Thuy Duong Zoe Tran (TDZ)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
MSc Programme in Drug Discovery & Pharmaceutical Sciences, University of Nottingham, Nottingham, UK.

Rohini Srivastava (R)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
MSc Programme in Drug Discovery & Pharmaceutical Sciences, University of Nottingham, Nottingham, UK.

Asuman Bunsuz (A)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Leire Borrega-Román (L)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Department of Pharmacology, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, Vitoria-Gasteiz, Spain.

Pattarin Hompluem (P)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Sean A Cullum (SA)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
MRC IMPACT Doctoral Training Programme, Universities of Birmingham, Leicester and Nottingham, Midlands, UK.

Clare R Harwood (CR)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
MRC IMPACT Doctoral Training Programme, Universities of Birmingham, Leicester and Nottingham, Midlands, UK.

Eline J Koers (EJ)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

David A Sykes (DA)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Iain B Styles (IB)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
School of Computer Science, University of Birmingham, Birmingham, UK.
The Alan Turing Institute, London, UK.

Dmitry B Veprintsev (DB)

Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH